Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Bühler

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
Journal of Cardiovascular Pharmacology|January 1, 1990
End-organ protection and antihypertensive therapy. IntroductionF R Bühler
Schweizerische Medizinische Wochenschrift|December 7, 1991
[Cardiovascular risk factors--an integrated sympathetic viewpoint]F R Bühler
Kidney International|August 1, 1989
Calcium antagonists as first-choice therapy for low-renin essential hypertensionF R Bühler
Cardiology|January 1, 1980
Antihypertensive beta-blockade and the renin-angiotensin systemF R Bühler
Zeitschrift Fur Kardiologie|January 1, 1984
Calcium antagonists, firstline partners for betablockers in hypertensionF R Bühler
Journal of Cardiovascular Pharmacology|January 1, 1988
Once-a-day calcium antagonist for antianginal and antihypertensive therapyF R Bühler
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibitionF R Bühler
Schweizerische Medizinische Wochenschrift|December 11, 1976
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age]F R Bühler
Cardiology|January 1, 1992
24-hour cardiovascular action and complianceF R Bühler
Schweizerische Medizinische Wochenschrift|December 5, 1987
[Does atrial antipressor natriuretic peptide play a pathophysiological role?]F R Bühler
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
Journal of Cardiovascular Pharmacology|January 1, 1990
End-organ protection and antihypertensive therapy. IntroductionF R Bühler
Schweizerische Medizinische Wochenschrift|December 7, 1991
[Cardiovascular risk factors--an integrated sympathetic viewpoint]F R Bühler
Kidney International|August 1, 1989
Calcium antagonists as first-choice therapy for low-renin essential hypertensionF R Bühler
Cardiology|January 1, 1980
Antihypertensive beta-blockade and the renin-angiotensin systemF R Bühler
Zeitschrift Fur Kardiologie|January 1, 1984
Calcium antagonists, firstline partners for betablockers in hypertensionF R Bühler
Journal of Cardiovascular Pharmacology|January 1, 1988
Once-a-day calcium antagonist for antianginal and antihypertensive therapyF R Bühler
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibitionF R Bühler
Schweizerische Medizinische Wochenschrift|December 11, 1976
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age]F R Bühler
Cardiology|January 1, 1992
24-hour cardiovascular action and complianceF R Bühler
Schweizerische Medizinische Wochenschrift|December 5, 1987
[Does atrial antipressor natriuretic peptide play a pathophysiological role?]F R Bühler
Pageof 34